0071483446.pdf

lincosamides, including clindamycins, 224–226, 226t
drug-drug interactions, 225
nursing diagnosis, 225–226
macrolide antibiotics, 222–224, 223t
drug-drug interactions, 224
nursing diagnosis, 224
medication
antimicrobials, 205–206
overview, 204–205
microorganisms, 204
miscellaneous antibiotics, 240–243, 240t–241t
overview, 203, 250–251
penicillin, 209–210, 211t–213t,214–215
drug-drug interactions, 214
nursing diagnosis, 214–215
patient education, 215
preparing to administer, 207–209
quiz, 251–252
sulfonamides, 241–243, 242t
superinfections, 206–207
tetracyclines, 232–234, 234t–235t
drug-drug interactions, 233
nursing diagnosis, 234
tuberculosis, 243–245, 243t
vancomycin, 226–228. 228t
drug-drug interactions, 227–228
nursing diagnosis, 228
Antiparkinsonism-anticholinergic drugs, 288–289,
289 t
Antiplatelet drugs, 365
Antipruritics, 378
Antipsychotics, 295–296, 297t
Anxiolytics, 296–297
Aprobarbital (Alurate), 275
Arthritis, 200
Aspirin, 70t, 199
interaction with aminoglycosides, 230
interaction with cephalosporins, 217
interaction with vancomycin, 227
Astemizole (Hismanal)
interaction with macrolides, 224
Asthma, 263–264
Atazanavir (Reyataz, ATV), 319
Atenolol (Tenormin), 286t, 352
Atorvastatin (Lipitor), 368
Attention deficit hyperactivity disorder (ADDHD),
271

Autonomic nervous system

adrenergics and adrenergic blockers, 284–286,

285 t–286t

fight or flight response, 283, 283t

overview, 281–282, 282t–283t

Azathioprine (Imuran), 325

Azithromyzin (Zithromax), 223t

Aztreonam (Azactam), 240t

Azulfidine, 407t

B

Bacampicillin (Spectrobid), 212t

Bacitracin

interaction with aminoglycosides, 230

interaction with vancomycin, 227

Baclofen (Lioresal), 290

Bactrim, 407t

Barbiturates, 275, 275t–276t, 294

days detectable in urine, 68t

Basics of pharmacology

drug effects, 7–8

drug names

brand/trade name, 6–7

chemical name, 6

generic name, 6

drug orders, 12–13, 13t–15t, 16

drug safety, 8–11

Phase I trials: initial pharmacological evaluation, 9

Phase II trials: limited controlled evaluation, 10

Phase III trials: extended clinical evaluation,

10–11

category A, 10

category B, 10

category C, 10

category D, 11

category X, 11

locating drug information, 11–12

overview, 1–3, 20–21

1970 Comprehensive Drug Abuse Prevent and

Control Act, 3

1952 Durham-Humphrey amendment to Food,

Drug and Cosmetic Act, 3

1938 Food, Drug and Cosmetic Act, 2–3

1962 Kefauver-Harris Amendment to Food, Drug

and Cosmetic Act, 3

prescription versus over-the-counter drugs, 7

quiz, 21–22

Index^439